Kelly Jason R
Transaction: 07/28/2026
BUY
Change
+74,258
Price
Not reported
Filing
07/30/2026
Type
BUY
Ginkgo Bioworks Holdings, Inc.
DNA • Biotechnology
$6.95
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$422.81M
Growth
8.4%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.82Healthy liquidity · 4.92Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:23 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.95
Change0.00%
Shares Out60.84M
Market Cap$422.81M
Enterprise Value$120.65M
52W Range5.37 - 17.58
Beta1.78
P/E-1.45
P/S5.85
P/B1.01
P/FCF-2.20
EV/Sales1.67
Price$6.95
Change0.00%
Shares Out60.84M
Market Cap$422.81M
Enterprise Value$120.65M
52W Range5.37 - 17.58
Beta1.78
P/E-1.45
P/S5.85
P/B1.01
P/FCF-2.20
EV/Sales1.67
EV/EBITDA-0.55
EV/FCF-0.63
Earnings Yield-68.78%
FCF Yield-45.40%
Dividend Yield0.00%
Gross Margin81.48%
Oper. Margin-185.29%
Profit Margin-183.81%
Debt/Eq0.82
Current Ratio4.92
Quick Ratio4.92
Revenue 5Y8.45%
Target$7.84
Target Upside12.81%
Target Median$7.50
Target Range4.35 - 12.00
Volume1.61M
Avg Volume1.21M
EPS Surprise-0.07
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
71/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Manageable debt level · 0.82Healthy liquidity · 4.92Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
50/100
Neutral
Bullish
4
Hold
3
Bearish
4
Price Target
2026-08-07
Low
$4.35
Mean
$7.84
Median
$7.50
High
$12.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Shetty Reshma P.
Transaction: 07/28/2026
BUY
Change
+35,736
Price
Not reported
Filing
07/30/2026
Type
BUY
Canton Barry
Transaction: 07/28/2026
BUY
Change
+35,736
Price
Not reported
Filing
07/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kelly Jason R | BUY | +74,258 | Not reported | 07/28/2026 | 07/30/2026 |
| Shetty Reshma P. | BUY | +35,736 | Not reported | 07/28/2026 | 07/30/2026 |
| Canton Barry | BUY | +35,736 | Not reported | 07/28/2026 | 07/30/2026 |
| Coen Steven P. | SELL | -752 | $7.90 | 07/17/2026 | 07/20/2026 |
| Coen Steven P. | SELL | -312 | Not reported | 07/16/2026 | 07/20/2026 |
| Coen Steven P. | BUY | +1,174 | Not reported | 07/16/2026 | 07/20/2026 |
| SLOAN HARRY | BUY | +25,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Kosuri Sri | BUY | +25,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Fubini Ross | BUY | +25,000 | Not reported | 06/11/2026 | 06/15/2026 |
| HENRY CHRISTIAN O | BUY | +25,000 | Not reported | 06/11/2026 | 06/15/2026 |
| Coen Steven P. | SELL | -307 | $8.33 | 05/22/2026 | 05/26/2026 |
| Coen Steven P. | SELL | -156 | Not reported | 05/21/2026 | 05/26/2026 |
| Coen Steven P. | BUY | +587 | Not reported | 05/21/2026 | 05/26/2026 |
| Coen Steven P. | SELL | -324 | $7.95 | 04/17/2026 | 04/20/2026 |
| Coen Steven P. | SELL | -156 | Not reported | 04/16/2026 | 04/20/2026 |
| Coen Steven P. | BUY | +587 | Not reported | 04/16/2026 | 04/20/2026 |
| Coen Steven P. | SELL | -33,171 | $6.41 | 04/13/2026 | 04/14/2026 |
| Coen Steven P. | SELL | -45,553 | Not reported | 04/10/2026 | 04/14/2026 |
| Coen Steven P. | BUY | +28,368 | Not reported | 04/10/2026 | 04/14/2026 |
| Shetty Reshma P. | SELL | -124,727 | $6.43 | 04/10/2026 | 04/13/2026 |